Baird Remains Buyers Of Gilead Before Earnings Release By: Benzinga via Benzinga January 29, 2015 at 14:18 PM EST In a report Thursday morning, analysts at Baird stated that they remain buyers of Gilead Sciences, Inc. (NASDAQ: GILD) before the ... Read More >> Related Stocks: AbbVie Express Scripts Holding Gilead Sciences